Glen Eagle Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Glen Eagle Advisors’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-58	Closed	-$3.95K	–	1186
2022 Q3	$3.95K	Buy	+58	New	+$3.2K	﹤0.01%	747

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Glen Eagle Advisors's GBT Position: Q4 2022 in Review

Glen Eagle Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 58 shares — an estimated $3.95K sold.

Glen Eagle Advisors first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $3.95K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Glen Eagle Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Glen Eagle Advisors sold 58 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $3.95K.
Glen Eagle Advisors first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
Glen Eagle Advisors's Global Blood Therapeutics, Inc. position peaked at $3.95K in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Glen Eagle Advisors's 13F filing for Q4 2022, filed 13 Aug 2024.